Paul Biondi, Senior Vice President & Head of Business Development
Why Partner With Us
With a long history of successful scientific and commercial collaborations that exhibit speed, collaboration, innovation, and strong partner relationships, research and development (R&D) is at the center of our strategy. With 41 compounds in development, a network of research facilities around the globe, and an annual R&D investment of $4.8 billion*, we’ve been recognized as one of the premier R&D organizations in the industry.
*This non-GAAP amount excludes significant upfront and milestone payments for business development transactions and other specified R&D items.
What We're Focused On
Contact us about partnering
Start the partnership process. Please send NON-CONFIDENTIAL information about your opportunity to one of the individuals below based on your area of interest:
Oncology: Fang Zhang firstname.lastname@example.org
Cardiovascular, Fibrosis and Immunoscience: Myra Beaudoin Bertrand email@example.com
Discovery Technology: Michael Cucolo firstname.lastname@example.org
PDx and Biomarker: Matt Bunn email@example.com